Protocol - Current Contraception Use - Female

Add to Toolkit

Protocol Name from Source:

National Survey of Family Growth


Publicly available


The woman is asked if she is pregnant, her general sexual intercourse frequency of this calendar year, whether she or her partner are physically able to conceive, and the type of contraceptive used.


1. Are you pregnant now?

[ ] 1 Yes

[ ] 2 No

2. Have you ever had both of your tubes tied, cut, or removed? This procedure is often called a tubal ligation or tubal sterilization.

[ ] 1 Yes (questions complete)

[ ] 2 No

3. Have you ever had a hysterectomy, that is, surgery to remove your uterus?

[ ] 1 Yes (questions complete)

[ ] 2 No

4. Has (HUSBAND/PARTNER) ever had a vasectomy or any other operation that would make it impossible for him to father a baby in the future?

[ ] 1 Yes (questions complete)

[ ] 2 No

5. (If currently sexually active and not sterilized) The last time that you had sexual intercourse, did you or your partner use any method of contraception?

[ ] 1 Yes

[ ] 2 No (questions complete)

6. (If used contraception at last intercourse) What contraceptive method did you or your partner use?

[ ] 3 Birth control pills

[ ] 4 Condom

[ ] 5 Partner’s vasectomy

[ ] 6 Female sterilizing operation, such as tubal sterilization and hysterectomy

[ ] 7 Withdrawal, pulling out

[ ] 8 Depo-Provera™, injectables

[ ] 9 Hormonal implant (Norplant™ , Implanon™, or Nexplanon™)

[ ] 10 Calendar rhythm, Standard Days, or Cycle Beads method

[ ] 11 Safe period by temperature or cervical mucus test (Two Day, Billings Ovulation, or Sympto-thermal Method)

[ ] 12 Diaphragm

[ ] 13 Female condom, vaginal pouch

[ ] 14 Foam

[ ] 15 Jelly or cream

[ ] 16 Cervical cap

[ ] 17 Suppository, insert

[ ] 18 Today™ sponge

[ ] 19 Intrauterine device (IUD), coil, loop (Mirena, Paraguard)

[ ] 20 Emergency Contraception

[ ] 21 Other method -- specify

[ ] 22 Respondent was sterile

[ ] 23 Respondent’s partner was sterile

[ ] 24 Lunelle™ injectable (monthly shot)*

[ ] 25 Contraceptive patch

[ ] 26 Vaginal contraceptive ring

*Lunelle is no longer available in the U.S.

Depo-Provera® is a registered trademark of Pfizer Inc.; Norplant® is the registered trademark of the Population Council for levonorgestrel-releasing capsule implants for protection against pregnancy; Today® is a registered trademark of Alvogen Group, Inc.

Personnel and Training Required

The interviewer must be trained to conduct personal interviews with individuals from the general population. The interviewer must be trained and found to be competent (i.e., tested by an expert) at the completion of personal interviews. The interviewer should be trained to prompt participants further if a "don’t know" response is provided.

Equipment Needs

If a computer-assisted instrument is used, computer software may be necessary to develop the instrument. The interviewer will require a laptop computer/handheld computer to administer a computer-assisted questionnaire.


Requirement CategoryRequired
Average time of greater than 15 minutes in an unaffected individualNo
Major equipmentNo
Specialized requirements for biospecimen collectionNo
Specialized trainingNo

Mode of Administration


Life Stage:

Adolescent, Adult

Specific Instructions:


Research Domain Information

Release Date:

April 11, 2017


Questions to assess participants’ use of contraception.


The purpose of these questions is to determine the type of contraceptive methods used by both female and male study participants. Certain methods, such as hormonal contraceptives, may be associated with gene/environment factors. Contraceptive methods might also be of interest as they relate to risk of sexually transmitted diseases.

Selection Rationale

This approach, which has been utilized in several national surveys, provides for minimal burden because it does not require extensive questioning.




Common Data Elements (CDE)Femal current Contraception Use Assessment Description Text3007431CDE Browser

Process and Review

The [link[www.phenx.org/node/110|Expert Review Panel #5]] (ERP 5) reviewed the measures in the Reproductive Health domain.

Guidance from ERP 5 includes:

· Changed the name of the measure

· Replaced protocol

· New Data Dictionary

Back-compatible: The original protocol from the National Survey of Family Growth (NSFG) 2003 Cycle 6, Women's Health Initiative 1998, and LIFE Study was updated to NSFG 2013-2015. The new protocol is a single source and includes more current contraceptive methods. There are changes to the Data Dictionary, previous version of the Data Dictionary and Variable mapping in Toolkit archive ([link[link|http://www.phenxtoolkit.org/index.php?pageLink=browse.archive.protocols&id=100000]])

Previous version in Toolkit archive ([link[www.phenxtoolkit.org/index.php?pageLink=resources.archive|link]]).


Centers for Disease Control and Prevention (CDC). National Survey of Family Growth, 2013-2015, BA-2, DA-1, DA-2, DA-8, EF-1, EF-2

General References

Lepkowski, J. M., Mosher, W. D., Davis, K. E., Groves, R. M., van Hoewyk, J., & Willem, J. (2006). National Survey of Family Growth, Cycle 6: Sample design, weighting, imputation, and variance estimation. Vital and Health Statistics, 2(142), 1-82.

Martinez, G. M., Chandra, A., Abma, J. C., Jones, J., & Mosher, W. D. (2006). Fertility, contraception, and fatherhood: Data on men and women from cycle 6 (2002) of the 2002 National Survey of Family Growth. Vital and Health Statistics, 23(26), 1-142.

Protocol ID:



Export Variables
Variable NameVariable IDVariable DescriptionVersiondbGaP Mapping